Stay updated on ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Sign up to get notified when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.

Latest updates to the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision (v3.4.2) was added to the study record history, indicating an update to the record. A site-wide government operating-status notice was removed.SummaryDifference0.8%

- Check21 days agoChange DetectedA site-wide notice about potential delays due to government funding and the current operating status was added, and the release note indicator was updated to 'Revision: v3.4.1'; the previous release note 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedThe history page now shows a glossary toggle and color-coded change highlights (green for additions, red for deletions). The revision text has been updated to v3.4.0.SummaryDifference1%

- Check42 days agoChange DetectedRevision v3.3.4 was added to the study record history, and revision v3.3.3 was removed. These updates modify the visible version history for NCT04419402.SummaryDifference0.1%

- Check64 days agoChange Detected- Added a new revision entry "Revision: v3.3.3" to the Record History. - Removed the "HHS Vulnerability Disclosure" item and "Revision: v3.3.2" from the footer/history.SummaryDifference0.2%

- Check85 days agoChange DetectedThe Record History page shows a new revision (v3.3.2) added and an earlier revision (v3.3.1) removed. This reflects an update to the page's version history rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.